Mental disorders in childhood: Shifting the focus from behavioral symptoms to neurodevelopmental trajectories

JAMA

Volumn 311, Issue 17, 2014, Pages 1727-1728

  Insel, Thomas R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID;

ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN MATURATION; CEREBROVASCULAR ACCIDENT; CHILDHOOD; CORONARY ARTERY DISEASE; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; FRONTAL CORTEX; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUNTINGTON CHOREA; ILLNESS TRAJECTORY; ISCHEMIC HEART DISEASE; MENTAL DISEASE; MORBIDITY; MORTALITY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; RECREATION; RISK ASSESSMENT; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SUBSTANCE ABUSE; THORAX PAIN;

ADOLESCENT; BEHAVIORAL SYMPTOMS; BRAIN; CHILD; CHILD DEVELOPMENT; COGNITION; HUMANS; MENTAL DISORDERS;

EID: 84899784690     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.1193     Document Type: Short Survey

References (9)

1. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591-608.
2. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-1586.
3. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication [published correction appears in Arch Gen Psychiatry. 2005;62(7):768]. Arch Gen Psychiatry. 2005;62(6):593-602.
4. Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007;104(49):19649-19654.
5. BrainSpan. BrainSpan: atlas of the developing human brain. http://www.brainspan.org. Accessed April 15, 2014.
6. Wolff JJ, Gu H, Gerig G, et al IBIS Network. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry. 2012;169(6):589-600.
7. Brent BK, Thermenos HW, Keshavan MS, Seidman LJ. Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child Adolesc Psychiatr Clin N Am. 2013;22(4):689-714.
8. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975-983.
9. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ. 2013;346:f185.